Certified by Founder Lodge
Dispatch Bio
- ND
START UP
1 Disclosed Funding Rounds $0
0 Participating Investments
-
Founded date
2022
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Established in 2022, Dispatch Bio was founded with a bold purpose: to help create a world where all cancer patients can be cured. To achieve this, the company is engineering a universal treat
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| July, 24 ,2025 | Series A | Undisclosed Amount |
Bristol Myers Squibb
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Transition Metal Solutions | $6,000,000 | (Jan 20, 2026)
Tulip Interfaces | $120,000,000 | (Jan 20, 2026)
Fanvue | $22,000,000 | (Jan 20, 2026)
Gutology | $2,418,300 | (Jan 20, 2026)
Fleetzero | $43,000,000 | (Jan 20, 2026)
